ALMS (Alumis Corp) רווח נקי למניה (EPS TTM)

The stability of Alumis Inc. (ALMS) relies on international patent protection, although foreign policy risks and trade barriers may complicate component logistics. This price chart shows that Alumis Inc. (ALMS) shares reflect EPS (TTM) dynamics, which currently stand at 9.60. Profit growth prospects are tied to the implementation of a unique therapy that enables pricing power, however, high development costs and regulatory requirements temporarily limit the scaling of business margins.

This indicator determines the dynamics of net earnings per share, assessing the stability of the company's financial trajectory. By analyzing the EPS YoY growth rate (trailing 12 months), an investor can see the percentage change in annual profit smoothed by day. The calculation is based on a comparison of the current total annual income with the same period of the previous cycle. For Alumis Inc. (ALMS), this metric is critical, as the absence of commercial products makes earnings dependent on the outcome of clinical trials.